Intercure Ownership

INCR Stock  ILS 478.90  14.10  2.86%   
Intercure has a total of 45.57 Million outstanding shares. Intercure secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Intercure in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Intercure, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intercure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Intercure Stock Ownership Analysis

About 38.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.43. Some equities with similar Price to Book (P/B) outperform the market in the long run. Intercure has Price/Earnings (P/E) ratio of 590.59. The entity had not issued any dividends in recent years. The firm had 1:4 split on the 8th of April 2021. InterCure Ltd. invests in the biomedical, life sciences, and biotechnology sectors in Israel and internationally. InterCure Ltd. was founded in 1994 and is based in Hadera, Israel. INTERCURE LTD is traded on Tel Aviv Stock Exchange in Israel. To learn more about Intercure call Alexander Rabinovitch at (972) 77 460 5012 or check out www.intercure.co.

Intercure Outstanding Bonds

Intercure issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Intercure uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Intercure bonds can be classified according to their maturity, which is the date when Intercure has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Intercure Stock

Intercure financial ratios help investors to determine whether Intercure Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Intercure with respect to the benefits of owning Intercure security.